Nalaganje...
Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy without Interfering with Chemotherapeutic Effect
Doxorubicin (DOX) is one of the most effective anticancer drugs. However, its cardiotoxicity remains a clinical concern that severely restricts its therapeutic usage. We designed this study to investigate whether tadalafil, a long-acting phosphodiesterase-5 (PDE-5) inhibitor, protects against DOX-in...
Shranjeno v:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
The American Society for Pharmacology and Experimental Therapeutics
2010
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2939673/ https://ncbi.nlm.nih.gov/pubmed/20543097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.110.170191 |
Oznake: |
Označite
Brez oznak, prvi označite!
|